Aromatase Inhibitors in Breast Cancer

A. Buzdar, J. Douma, N. Davidson, R. Elledge, M. Morgan, R. Smith, L. Porter, J. Nabholtz, X. Xiang, C. Brady, Phase III, Multicenter, Double-Blind, Randomized Study of Letrozole, an Aromatase Inhibitor, for Advanced Breast Cancer Versus Megestrol Acetate Journal of Clinical Oncology. ,vol. 19, pp. 3357- 3366 ,(2001) , 10.1200/JCO.2001.19.14.3357

Per Eystein Lønning, Emilio Bajetta, Robin Murray, Michele Tubiana-Hulin, Peter D Eisenberg, Elizabeth Mickiewicz, Luigi Celio, Paula Pitt, Monica Mita, Neil K Aaronson, Camilla Fowst, Alexei Arkhipov, Enrico di Salle, Anna Polli, Giorgio Massimini, None, Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial Journal of Clinical Oncology. ,vol. 18, pp. 2234- 2244 ,(2000) , 10.1200/JCO.2000.18.11.2234

A Buzdar, W Jonat, A Howell, S E Jones, C Blomqvist, C L Vogel, W Eiermann, J M Wolter, M Azab, A Webster, P V Plourde, Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. Journal of Clinical Oncology. ,vol. 14, pp. 2000- 2011 ,(1996) , 10.1200/JCO.1996.14.7.2000

Henning Mouridsen, Mikhail Gershanovich, Yan Sun, Ramón Pérez-Carrión, Corrado Boni, Alain Monnier, Justus Apffelstaedt, Robert Smith, Harm P. Sleeboom, Fritz Jänicke, Anna Pluzanska, Magdolna Dank, Dominique Becquart, Poonamalle P. Bapsy, Eeva Salminen, Ray Snyder, Mercedes Lassus, J. Arnold Verbeek, Beatrix Staffler, Hilary A. Chaudri-Ross, Margaret Dugan, Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group Journal of Clinical Oncology. ,vol. 19, pp. 2596- 2606 ,(2001) , 10.1200/JCO.2001.19.10.2596

, Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex and tamoxifen alone or in combination' (ATAC) trial. British Journal of Cancer. ,vol. 85, pp. 317- 324 ,(2001) , 10.1054/BJOC.2001.1925

A L Jones, T J Powles, M Law, A Tidy, D Easton, R C Coombes, I E Smith, J A McKinna, A Nash, H T Ford, Adjuvant aminoglutethimide for postmenopausal patients with primary breast cancer: analysis at 8 years. Journal of Clinical Oncology. ,vol. 10, pp. 1547- 1552 ,(1992) , 10.1200/JCO.1992.10.10.1547

J.M. Nabholtz, A. Buzdar, M. Pollak, W. Harwin, G. Burton, A. Mangalik, M. Steinberg, A. Webster, M. von Euler, Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial Journal of Clinical Oncology. ,vol. 18, pp. 3758- 3767 ,(2000) , 10.1200/JCO.2000.18.22.3758

P Dombernowsky, I Smith, G Falkson, R Leonard, L Panasci, J Bellmunt, W Bezwoda, G Gardin, A Gudgeon, M Morgan, A Fornasiero, W Hoffmann, J Michel, T Hatschek, T Tjabbes, H A Chaudri, U Hornberger, P F Trunet, Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. Journal of Clinical Oncology. ,vol. 16, pp. 453- 461 ,(1998) , 10.1200/JCO.1998.16.2.453

A. Hamilton, M. Piccart, The third-generation non-steroidal aromatase inhibitors: A review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer Annals of Oncology. ,vol. 10, pp. 377- 384 ,(1999) , 10.1023/A:1008368300827

H B Muss, L D Case, J N Atkins, J D Bearden, M R Cooper, J M Cruz, D V Jackson, M A O'Rourke, M D Pavy, B L Powell, Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study. Journal of Clinical Oncology. ,vol. 12, pp. 1630- 1638 ,(1994) , 10.1200/JCO.1994.12.8.1630